Matthew Schlumbrecht

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 367 citations

Tisotumab Vedotin, Cervical Cancer, Metastatic Cervical Cancer +8

Rate of vaginal cuff separation following laparoscopic or robotic hysterectomy

Alpa M. Nick, J Lange, Michael Frumovitz et al. · Gynecologic Oncology · 2010 · 84 citations

Gynecologic Surgery, Laparoscopy, Robotic Technology +6

Pericytoma With t(7;12) and ACTB-GLI1 Fusion

Darcy A. Kerr, André Pinto, Ty K. Subhawong et al. · The American Journal of Surgical Pathology · 2019 · 69 citations · Full text

Gene Sequencing for Pathogenic Variants Among Adults With Breast and Ovarian Cancer in the Caribbean

Sophia George, Talia Donenberg, Cheryl Alexis et al. · JAMA Network Open · 2021 · 68 citations · Full text

S100A4 mediates endometrial cancer invasion and is a target of TGF-β1 signaling

Ran Xie, Matthew Schlumbrecht, Gregory L. Shipley et al. · Laboratory Investigation · 2009 · 54 citations · Full text

Tumor Biology, Endometrial Cancer Invasion, Signaling Pathway +8